Related vendor names: WarmMark, FreezeSafe, ShockWatch, TiltWatch, HemoTemp, ColdMark, ColdSnap, Telatemp, SpotSee Cloud
SpotSee

SpotSee

QR-enabled indicators and condition sensors document temperature, impact, and handling events across pharma supply chains.

Visit Website

Known For

Battery-free, QR-enabled condition indicators that turn package-level temperature, shock, tilt, and handling events into auditable shipment evidence.

Key Differentiators

  • QR-enabled WarmMark, FreezeSafe, ShockWatch, and TiltWatch indicators
  • HemoTemp II and blood-product temperature monitoring workflows
  • SpotSee Cloud records scan status, time, location, serial number, and evidence
  • Telatemp acquisition added ColdSnap and ColdSnap+ indicator breadth
  • Controlant collaboration for layered life-sciences monitoring

Overview

SpotSee is a condition-indicator and sensor manufacturer that documents what happened to a shipment: temperature excursions, freeze events, shock, impact, tilt, vibration, humidity, and liquid exposure. Its buyer value is proof of condition, not thermal shipper supply or freight operation. SpotSee is owned by Harbour Group; the 2025 Telatemp acquisition added ColdSnap and ColdSnap+ to the indicator portfolio.

SpotSee is a condition-evidence indicator vendor, not a thermal packaging manufacturer, real-time logging platform, or logistics operator. It is most relevant as the condition-monitoring layer around cold-chain packaging and distribution lanes; its QR-enabled products (WarmMark QR, FreezeSafe QR, ShockWatch 2 QR, ShockWatch Label QR, TiltWatch XTR QR) create scan-based records in SpotSee Cloud with condition status, time, location, serial number, and supporting evidence. Pair SpotSee with packaging, logistics, or real-time monitoring partners (Controlant for life-sciences telematics; Parsyl for insurance-linked data) when the buyer needs full lane execution.

Cold Chain and Packaging Capability Model

The framework below standardizes how Rx Almanac evaluates packaging-contract-manufacturing capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, SpotSee is evaluated as condition-indicator and sensor manufacturer that documents what happened to a shipment: temperature excursions, freeze events, shock, impact, tilt, vibration, humidity, and liquid exposure.

CapabilityBuyer should compareSpotSee readout
Temperature range and packaging formatsAmbient, CRT, 2-8C, frozen, ultra-cold, cryogenic, parcel, pallet, active, and passive configurations.Monitoring-focused. SpotSee documents time-temperature, freeze, blood-product, and condition indicators; validate the actual packaging or lane partner separately.
Qualification, validation, and lane designISTA/GDP qualification, thermal modeling, lane profiles, SOPs, stability assumptions, and validation documentation.Confirm qualification package in the RFP. Ask which indicator thresholds, cloud records, audit controls, and SOPs have been validated for the specific product and lane.
Reusable, rental, and sustainability modelReusable shipper programs, rental pools, reverse logistics, waste reduction, carbon reporting, and cost per use.Not the core buying object. SpotSee is primarily an indicator and condition-evidence vendor, not a reusable shipper fleet or rental packaging provider.
Monitoring, sensors, and excursion responseTemperature indicators, IoT sensors, real-time tracking, excursion triage, and quality documentation.Core monitoring layer. QR-enabled indicators, SpotSee Cloud, HemoTemp II, ShockWatch, TiltWatch, WarmMark, ColdMark, FreezeSafe, and partner-enabled real-time monitoring.
Global logistics support and availabilityManufacturing footprint, inventory availability, international compliance, distribution partners, and launch surge reliability.Documented distribution, validate launch capacity. SpotSee reports broad customer/partner reach and global distribution, but buyers should confirm supply, local availability, and support SLAs.
Specialty, biologic, and CGT readinessSuitability for high-value biologics, cell/gene therapies, clinical supply, specialty pharmacy, or direct-to-patient shipments.Documented for biologics and specialty lanes. Best fit is high-volume condition evidence around vaccines, biologics, diagnostics, blood products, and specialty shipments.

Buyer Fit

  • Right buying motion: Use SpotSee when a program needs shipment-level condition evidence at scale: QR scan records, indicator thresholds, receiving checks, and exception documentation across cold-chain handoffs.
  • Best-fit buyers: Pharma manufacturers, biotechs, vaccine programs, blood-product networks, diagnostics shippers, and specialty distributors that need auditable condition evidence per parcel.
  • Less ideal fit: Programs whose primary need is real-time IoT visibility, in-transit intervention, thermal packaging supply, or freight execution should evaluate Controlant, Sensitech, Sonoco ThermoSafe, or a 3PL respectively.
  • Commercial fit: Custom/RFP pricing; define thresholds, device mix, scan workflow, SpotSee Cloud access, data-retention needs, integration handoffs, and evidence ownership in the statement of work.
  • Integration diligence: Confirm threshold selection, audit controls, data ownership, Part 11 / quality-system fit, who scans at each handoff, and which partner owns real-time tracking, packaging, freight, and disposition.

Differentiators

  • QR-enabled condition evidence: WarmMark QR, FreezeSafe QR, ShockWatch 2 QR, ShockWatch Label QR, and TiltWatch XTR QR extend low-cost scan evidence into package-level and last-mile handoffs.
  • SpotSee Cloud recordkeeping: Scan records can capture condition status, time, location, serial number, and supporting evidence for quality review and receiving workflows.
  • Life-sciences indicator breadth: HemoTemp II, WarmMark, ColdMark, FreezeSafe, ColdSnap, and related products support blood products, biologics, diagnostics, vaccines, and specialty shipments.
  • Layered monitoring partnerships: The Controlant collaboration pairs SpotSee indicators with real-time monitoring infrastructure for life-sciences lanes that need both continuous data and local proof of condition.
  • Risk-economics adjacency: The Parsyl partnership points to a monitoring-data use case beyond quality documentation: shipment-risk evidence that can support insurance and loss-prevention programs.

RFP Questions

  • Which indicator thresholds, activation windows, and scan workflows match the product’s stability profile and release procedures?
  • What evidence is captured at scan, how is it stored in SpotSee Cloud, and how does it map to Part 11, audit, and quality-system requirements?
  • Which party scans at each handoff: manufacturer, 3PL, carrier, specialty pharmacy, site of care, or receiving customer?
  • Which partner owns real-time tracking, lane design, thermal packaging, freight execution, and final disposition when SpotSee is one component of the monitoring stack?
  • How will exception data flow into the manufacturer’s quality system, logistics control tower, insurance process, or recall / return workflow?

Recent Activity

  • 2026-04: Expanded QR-enabled portfolio with FreezeSafe QR, TiltWatch XTR QR, and ShockWatch Label QR.
  • 2026-03: Announced a Controlant collaboration for life-sciences shipment visibility and last-mile proof, plus a Parsyl partnership tied to insurance rewards for monitored shipments.
  • 2026-01: Introduced ShockWatch 2 QR as a connected impact indicator.
  • 2025: Acquired Telatemp, adding ColdSnap and ColdSnap+ cold-chain indicator capabilities; launched WarmMark QR.

Curated by Rx Almanac using company materials and public reporting.